MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cgh.2026.09.002

Медицинская библиотека · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2026

Spleen and liver two-dimensional shear wave elastography for clinically significant portal hypertension.

Sebesta Christian, Jachs Mathias, Hartl Lukas, Schwarz Michael, Balcar Lorenz, Hofer Benedikt S, Dominik Nina, Kramer Georg, Thöne Paul, Berzigotti Annalisa, Cabello Calleja Josune, García-Pagán Juan Carlos, Morosan Ioana, Sebastian McCoy Martin, Procopeț Bogdan, Ștefănescu Horia, Trebicka Jonel, Uschner Frank Erhard, Elkrief Laure, Rautou Pierre-Emmanuel, Scheiner Bernhard, Stättermayer Albert F, Simbrunner Benedikt, Schöchtner Till, Haimberger Friedrich, Balutsch Nicolas, Trauner Michael, Mandorfer Mattias, Reiberger Thomas, Bauer David J M

СтатьяПеревод в очереди

Аннотация

BACKGROUND & AIMS: Liver (LSM) and spleen (SSM) stiffness measurements correlate with hepatic venous pressure gradient (HVPG), the reference standard for defining clinically significant portal hypertension (CSPH, i.e. HVPG ≥10 mmHg). LSM, SSM and derived scores have been proposed for non-invasive CSPH risk assessment.

METHODS

Compensated advanced chronic liver disease (cACLD) patients undergoing same-day HVPG, Supersonic (SSI)-LSM, and SSI-SSM were prospectively included. Reliable SSI-LSM and SSI-SSM were defined by IQR/Med ≤30%. SSI-LSM, SSI-SSM and derived Baveno VII rules, Anticipate-SSI, LPS-SSI, and the newly developed SSI-4PH (LSM/SSM, platelet count: PLT, BMI) model were evaluated in a derivation cohort (DeCo) and an external validation cohort (VaCo).

RESULTS

The DeCo comprised 220 patients, paired reliable SSI-LSM/SSI-SSM measurements were available in 118 (53.6%) patients including 74.6% with CSPH. The VaCo comprised 86 eligible patients, of whom 73 (84.9%) had paired reliable measurements including 43.8% with CSPH. In reliable paired analyses, AUROCs for CSPH detection in the DeCo were 0.84 for Anticipate-SSI, 0.87 for LPS-SSI, and 0.90 for SSI-4PH; the corresponding AUROCs in the VaCo were 0.78, 0.77, and 0.73. At the fixed ≥75% predicted-risk threshold, specificity of SSI-4PH was 83.3% in the DeCo and 87.8% in the VaCo.

CONCLUSIONS

Reliable SSI-LSM and SSI-SSM provide robust non-invasive assessment of CSPH risk, however, the requirement of reliable (IQR/Med ≤30%) paired measurements may limit applicability. Combined SSI-LSM/SSM-based rules and multivariable models reduced gray-zone, and the SSI-4PH yielded a favorable decision-curve utility for CSPH risk assessment.

Для цитирования: Sebesta Christian, Jachs Mathias, Hartl Lukas, Schwarz Michael, Balcar Lorenz, Hofer Benedikt S, Dominik Nina, Kramer Georg, Thöne Paul, Berzigotti Annalisa, Cabello Calleja Josune, García-Pagán Juan Carlos, Morosan Ioana, Sebastian McCoy Martin, Procopeț Bogdan, Ștefănescu Horia, Trebicka Jonel, Uschner Frank Erhard, Elkrief Laure, Rautou Pierre-Emmanuel, Scheiner Bernhard, Stättermayer Albert F, Simbrunner Benedikt, Schöchtner Till, Haimberger Friedrich, Balutsch Nicolas, Trauner Michael, Mandorfer Mattias, Reiberger Thomas, Bauer David J M. Spleen and liver two-dimensional shear wave elastography for clinically significant portal hypertension.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2026. DOI: 10.1016/j.cgh.2026.09.002.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.